z-logo
Premium
Bone marrow karyotypes in 94 children with acute leukemia
Author(s) -
Heim S.,
Békàssy A. N.,
Garwicz S.,
Heldrup J.,
Kristoffersson U.,
Mandahl N.,
Wiebe T.,
Mitelman F.
Publication year - 1990
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1990.tb00384.x
Subject(s) - karyotype , chromosomal translocation , leukemia , bone marrow , acute leukemia , chromosome , cytogenetics , pathology , biology , medicine , gastroenterology , immunology , genetics , gene
During the last 10 years, we have cytogenetically analyzed at diagnosis bone marrow cells from a total of 94 children with acute leukemia. Of the 78 children with acute lymphatic leukemia (ALL), 53 (68%) had clonal acquired chromosome abnormalities; in the group with acute nonlymphatic leukemia (ANLL), the corresponding proportion was 13 out of 16 (81%). Among the cytogenetically abnormal ALL patients, the most numerous subset was the hyperdiploid cases with stemlines containing 51 or more chromosomes (26 of 53 abnormal cases; 49%). This is a clearly higher proportion than has been reported in large series from other centers. Deletions of 6q were present in 8 cases and rearrangements of 12p in 5. Of the 7 T‐cell ALLs, 3 had translocations of the distal part of 7q, i.e., of the region where the beta T‐cell receptor is encoded. Only 2 of 26 (8%) patients with leukemic stemlines with more than 50 chromosomes have relapsed; the remainder are still in first remission (mean observation time 42 months). This may be contrasted with 6 of 25 (24%) relapses among the cytogenetically normal (observation time 41 months), and 8 of 27 (30%) relapses among ALL patients with aberrations but with less than 51 chromosomes (observation time 26 months). Our results support the conclusion that the finding of a markedly hyperdiploid leukemia karyotype is indicative of good prognosis in ALL.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here